Text Messaging Program for Pregnancy Health
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a text messaging program called SmartMom, designed to help pregnant individuals make healthier choices during pregnancy. The researchers aim to determine if these messages can improve pregnancy knowledge, reduce depression and anxiety, and lead to better health outcomes for both mother and baby. Participants will receive either three weekly text messages promoting healthy habits or general pregnancy information (control text messaging). Eligible participants must be pregnant with one baby, free of certain health conditions, and reside in Canada (excluding British Columbia). As an unphased trial, this study provides a unique opportunity to contribute to research that could enhance pregnancy care for many.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, if you have health conditions that require individualized care, you may not be eligible to participate.
What prior data suggests that this text messaging program is safe for pregnant individuals?
Research has shown that the SmartMom text messaging program is safe for pregnant people. This program sends scientifically-based information to encourage healthy habits during pregnancy. Previous studies aimed to improve prenatal education without causing harm. No reports of negative effects from receiving these text messages exist. Instead, the program offers useful information to support a healthy pregnancy. Since this trial is at a stage where safety is generally well-established, participants can feel confident about the program's safety.12345
Why are researchers excited about this trial?
Researchers are excited about the SmartMom text messaging program because it offers a proactive and personalized approach to promoting healthy behaviors during pregnancy. Unlike standard prenatal care, which often relies on in-person visits and general advice, SmartMom provides timely, evidence-based information directly to expectant mothers' phones three times a week. This method aims to empower women with the knowledge they need to make healthier choices throughout their pregnancy, potentially improving outcomes for both mother and baby.
What evidence suggests that the SmartMom text messaging program is effective for improving pregnancy health?
This trial will compare the SmartMom text messaging program with a control messaging program. Research has shown that the SmartMom program can enhance health during pregnancy. Participants in the SmartMom messaging arm will receive messages based on proven research to support positive changes during pregnancy. Canadian women contributed to the creation of these messages to ensure they are useful and relevant. Early results suggest that programs like this can increase knowledge about pregnancy and improve mental health and childbirth experiences. Meanwhile, participants in the control messaging arm will receive general information about pregnancy but not about making healthy choices.12356
Who Is on the Research Team?
Patti Janssen, PhD
Principal Investigator
University of British Columbia
Are You a Good Fit for This Trial?
This trial is for pregnant individuals in Canada (except British Columbia) who are at or before 15 weeks gestation with a single pregnancy. They must be able to read and understand English at an 8th-grade level and be comfortable completing online surveys.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive text messages promoting healthy behaviours during pregnancy
Control
Participants receive general interest messages on pregnancy-related topics
Follow-up
Participants are monitored for maternal, fetal, and newborn outcomes post-birth
What Are the Treatments Tested in This Trial?
Interventions
- Control text messaging
- SmartMom text messaging
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator